‌

Nano Terra, Inc. SBIR Phase II Award, August 2022

A SBIR Phase II contract was awarded to Nano Terra, Inc. in August, 2022 for $1,096,531.0 USD from the U.S. Department of Defense and Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense.

Overview Structured Data Issues Contributors

sbir.gov/node/2321159

Is a

SBIR/STTR Awards

SBIR/STTR Award attributes

SBIR/STTR Award Recipient

Nano Terra, Inc.

Government Agency

U.S. Department of Defense

Government Branch

Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense

Award Type

SBIR0

Contract Number (US Government)

HDTRA1-22-C-00090

Award Phase

Phase II0

Award Amount (USD)

1,096,5310

Date Awarded

August 29, 2022

End Date

August 28, 2024

Abstract

Wounds sustained in a chemically contaminated environment are uniquely challenging to treat. Current methods include irrigation with water or a lavage solution and packing with standard gauze. These methods fail to detoxify any chemical warfare agent (CWA) present on the wound and result in a contaminated “hot” gauze which complicates safety and environmental considerations for the patient and medical personnel. Our product rapidly absorbs and detoxifies CWA, addressing this unmet need. The ultimate goal of this effort is FDA clearance of our product as a medical device.